Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Sichuan Mental Health ; (6): 561-565, 2022.
Artigo em Chinês | WPRIM | ID: wpr-987364

RESUMO

ObjectiveTo explore the effects of group interpersonal psychotherapy (IPT) on cognitive and social function in patients with first-episode schizophrenia, and to provide references for appropriate psychological treatment for the patients. MethodsA total of 62 patients with first-episode schizophrenia who met the diagnostic criteria of International Classification of Diseases, tenth edition (ICD-10) and were admitted to the Third People's Hospital of Foshan from January to December 2021 were selected as the study objects. And patients were divided into study group and control group according to random number table method, each with 31 cases. Both groups were treated with risperidone for 8 weeks, based on this, study group received group IPT. Before and after 8 weeks of treatment, Positive and Negative Syndrorne Scales (PANSS), Wisconsin Card Sorting Tests (WCST) and Personal and Social Performance Sale(PSP) were adopted to assess the patients' psychiatric symptoms, cognitive function and social function. ResultsAfter 8 weeks of treatment, there was no significant difference in PANSS scores between the two groups (t=0.296, P>0.05). The WCST total number of responses in the study group was larger than that in the control group, the number of perseverative errors and non-perseverative errors were smaller than those in the control group, and PSP score of the study group was higher than that of the control group, with statistically significant differences (t=0.398, 2.609, 0.523, 0.381, P<0.05 or 0.01). ConclusionGroup IPT may have no significant efficacy on alleviating the symptoms of patients with first-episode schizophrenia, but it may help improve the cognitive and social function in patients.

2.
Sichuan Mental Health ; (6): 239-242, 2021.
Artigo em Chinês | WPRIM | ID: wpr-987524

RESUMO

ObjectiveTo investigate the efficacy and safety of venlafaxine in the treatment of depression under the guidance of pharmacogenomics testing, and to provide references for individualized medication. MethodsA total of 66 patients who met the diagnostic criteria of International Classification of Diseases, tenth edition (ICD-10) for depressive episode were included in the study. Patients who were recommended to be treated with venlafaxine in the pharmacogenomics testing report were divided into study group (n=32), and those who were decided to be treated with venlafaxine by doctors after consultation with patients were divided into control group (n=34). At the baseline and the end of the 2nd, 4th, 6th and 8th weekend of treatment, Hamilton Depression Scale-24 item (HAMD-24) was adopted to evaluate the clinical efficacy. Meanwhile, Sheehan Disability Scale (SDS) was applied to measure the social function of patients at the baseline and the end of the 8th weekend of treatment. After treatment, Treatment Emergent Symptom Scale (TESS) was used to assess the incidence of adverse reactions. ResultsAt the end of the 4th, 6th and 8th weekend of treatment, HAMD-24 scores in the study group were all lower than those in the control group, with statistical differences (t=2.344, 4.316, 5.760, P<0.05 or 0.01). At the end of the 8th weekend of treatment, SDS score of the study group was lower than that of the control group, with statistical difference (t=2.173, P<0.05). The adverse reaction rate in the study group was lower than that in the control group, with statistical difference (χ2=5.720, P<0.05). ConclusionTreatment of depression with venlafaxine based on pharmacogenetic testing is an effective and safe way to alleviate the depression symptoms in patients.

3.
Chinese Journal of Nosocomiology ; (24)2006.
Artigo em Chinês | WPRIM | ID: wpr-588378

RESUMO

OBJECTIVE To estimate the cost of concentrated disinfectant supply of medical appliances,so as to provide the primary basis for improving the concentrated disinfectant supply model,along with regional integration.METHODS Using contrasting methodologies,the cost level before and after the concentrated disinfectant supply with regional integration was compared,and the individual cost and total cost were analyzed.RESULTS Material and human resource cost was the core of total cost.Concentration management of regional medical appliances disinfection supply could significantly reduce costs.CONCLUSIONS Integrated management of concentrated disinfectant supply could reduce cost and economize expenses.Actually,this model is worth promoting.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA